Current Assets、製品補償関連費用、B OpeCF他4件
- 【期間】
年度 | Current Assets | 製品補償関連費用 | B OpeCF | Capital Expenditures Overview Of Capital Expenditures Etc - Chemicals Reportable Segments Member | Deferred Tax LiabilitiesCL | 社債償還損 | 試作品売却収入 |
---|
2013/09 | - | 335百万 | - | - | - | - | - |
2016/09 | - | - | - | - | - | - | 18百万 |
2017/09 | - | - | - | - | - | 16億 | 248百万 大幅増 |
2018/09 | - | - | - | - | - | - | 308百万 +24.2% |
2020/09 | - | - | - | - | - | - | 93百万 -69.8% |
2021/09 | - | - | - | - | - | - | 346百万 +272% |